Intuitive Surgical (ISRG) Other Non-Current Liabilities (2009 - 2026)
Intuitive Surgical (ISRG) posted Other Non-Current Liabilities of $656.0 million for Q2 2026, up 8.83% on a QoQ basis from $602.8 million in Q1 2026, and up 26.76% year-over-year from $517.5 million in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Other Non-Current Liabilities for 18 years, with the latest figure at $656.0 million in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 26.76% year-over-year to $656.0 million in Q2 2026; TTM through Jun 2026 was $656.0 million, a 26.76% increase from a year earlier, with the FY2025 full-year figure at $510.8 million, up 9.08% from the prior year.
- Other Non-Current Liabilities was $656.0 million for Q2 2026 at Intuitive Surgical, up from $602.8 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $656.0 million in Q2 2026, with the low at $365.9 million in Q2 2024.
- Average Other Non-Current Liabilities over 5 years is $461.3 million, with a median of $449.7 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Liabilities slipped 12.25% in 2023, then surged 41.43% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $439.3 million in 2022, then slipped by 12.25% to $385.5 million in 2023, then advanced by 21.48% to $468.3 million in 2024, then climbed by 9.08% to $510.8 million in 2025, then climbed by 28.43% to $656.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $656.0 million (Q2 2026), $602.8 million (Q1 2026), and $510.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 656.00 Mn |
| Mar 31, 2026 | 602.80 Mn |
| Dec 31, 2025 | 510.80 Mn |
| Sep 30, 2025 | 506.50 Mn |
| Jun 30, 2025 | 517.50 Mn |
| Mar 31, 2025 | 474.60 Mn |
| Dec 31, 2024 | 468.30 Mn |
| Sep 30, 2024 | 389.10 Mn |
| Jun 30, 2024 | 365.90 Mn |
| Mar 31, 2024 | 406.50 Mn |
| Dec 31, 2023 | 385.50 Mn |
| Sep 30, 2023 | 412.80 Mn |
| Jun 30, 2023 | 405.20 Mn |
| Mar 31, 2023 | 451.60 Mn |
| Dec 31, 2022 | 439.30 Mn |
| Sep 30, 2022 | 453.40 Mn |
| Jun 30, 2022 | 447.80 Mn |
| Mar 31, 2022 | 409.30 Mn |
| Dec 31, 2021 | 453.70 Mn |
| Sep 30, 2021 | 447.80 Mn |